Alterations in the gut microbiota of alcoholic cirrhosis patients infected with Clonorchis sinensis in the Pearl River Delta region of ChinaOriginal paper
What was studied?
This study asked how infection with the liver fluke Clonorchis sinensis changes the gut microbiota in people with alcoholic cirrhosis (ALC). Researchers sequenced the 16S rRNA gene (V3-V4 regions) in stool. They compared infected and uninfected patients on diversity, composition, genus correlations, and predicted function. LEfSe identified marker taxa and Tax4Fun2 predicted KEGG metabolic pathways.
Who was studied?
The cohort was 64 adults diagnosed with alcoholic cirrhosis at the Guangdong Provincial Hospital of Traditional Chinese Medicine, in the Pearl River Delta region of China. All were Han Chinese with similar diets. Half (32) were co-infected with C. sinensis and half (32) were not, mostly men. Infection was confirmed by detecting fluke eggs in feces. This was a single-center human study; no healthy control group was included.
What were the most important findings?
Alpha diversity did not differ between groups, but beta diversity did: ANOSIM (R=0.051, p=0.018) and PERMANOVA (R-squared=0.027, p=0.012). Fusobacteriota rose and Proteobacteria fell in infected patients. LEfSe flagged 22 taxa; the phylum Firmicutes and genus Prevotella scored highest as markers of infection. Enterococcus showed strong negative correlations with many genera only in infected patients. The vancomycin-resistance pathway was the most divergent KEGG function (p=0.0088).
What are the greatest implications of this study?
The results suggest C. sinensis infection restructures the gut microbiota and its interaction networks in alcoholic cirrhosis. Prevotella and Enterococcus may be candidate diagnostic or therapeutic targets. The enriched vancomycin-resistance signal raises concern about antibiotic-resistant infection risk in these patients. Because this was a small single-center study without healthy controls, the observed shifts may reflect combined effects and need larger multi-center confirmation.